Stuart Arbuckle
Chief Operating Officer presso VERTEX PHARMACEUTICALS INCORPORATED
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Stuart A. Arbuckle è un direttore indipendente di Rhythm Pharmaceuticals, Inc., un direttore indipendente di ImmunoGen, Inc. e un direttore operativo e vicepresidente esecutivo di Vertex Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Rhythm Pharmaceuticals, Inc., ImmunoGen, Inc., Biotechnology Innovation Organization e Cancer Support Community. Il signor Arbuckle è stato precedentemente impiegato come vicepresidente e GM-Oncology Business Unit di Amgen, Inc. e come direttore di GlaxoSmithKline Plc. È stato anche membro del consiglio di amministrazione di Cerulean Pharma, Inc. e di Wellness Community. Si è laureato all'Università di Leeds.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
18/03/2024 | 3 932 ( 0.00% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Stuart Arbuckle
Società | Posizione | Inizio |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 01/02/2021 |
RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2019 |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Director/Board Member | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Precedenti posizioni note di Stuart Arbuckle
Società | Posizione | Fine |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12/02/2024 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 01/07/2017 |
AMGEN INC. | Corporate Officer/Principal | 01/08/2012 |
GSK PLC | Corporate Officer/Principal | - |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Director/Board Member | - |
Formazione di Stuart Arbuckle
University of Leeds | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
AMGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
Aziende private | 4 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Stuart Arbuckle